[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1007081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 48, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 61, "title": "CFO & Head of Corporate Development", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caryn Gordon McDowell J.D.", "age": 55, "title": "Chief Legal Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin  Andrulevich", "age": 59, "title": "Chief People Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 45, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 35.97, "open": 35.91, "dayLow": 34.26, "dayHigh": 36.46, "regularMarketPreviousClose": 35.97, "regularMarketOpen": 35.91, "regularMarketDayLow": 34.26, "regularMarketDayHigh": 36.46, "payoutRatio": 0.0, "beta": -0.281, "forwardPE": -28.3459, "volume": 2156317, "regularMarketVolume": 2156317, "averageVolume": 4149593, "averageVolume10days": 2313850, "averageDailyVolume10Day": 2313850, "bid": 34.21, "ask": 34.48, "bidSize": 12, "askSize": 5, "marketCap": 3733980928, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 48.26, "allTimeHigh": 48.26, "allTimeLow": 1.45, "fiftyDayAverage": 34.776, "twoHundredDayAverage": 13.117575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2797832960, "profitMargins": 0.0, "floatShares": 66428434, "sharesOutstanding": 108767281, "sharesShort": 15452240, "sharesShortPriorMonth": 8781897, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.1421, "heldPercentInsiders": 0.00597, "heldPercentInstitutions": 0.82639, "shortRatio": 3.41, "shortPercentOfFloat": 0.1421, "impliedSharesOutstanding": 108767281, "bookValue": 3.246, "priceToBook": 10.576094, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -94435000, "trailingEps": -1.02, "forwardEps": -1.21111, "enterpriseToEbitda": -25.827, "52WeekChange": 6.5783663, "SandP52WeekChange": 0.15024745, "quoteType": "EQUITY", "currentPrice": 34.33, "targetHighPrice": 70.0, "targetLowPrice": 54.0, "targetMeanPrice": 58.125, "targetMedianPrice": 56.5, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 295635008, "totalCashPerShare": 3.282, "ebitda": -108331000, "totalDebt": 1029000, "quickRatio": 19.213, "currentRatio": 19.516, "debtToEquity": 0.362, "returnOnAssets": -0.19944, "returnOnEquity": -0.29123, "freeCashflow": -51270876, "operatingCashflow": -77677000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": 1.7186027, "postMarketPrice": 34.92, "postMarketChange": 0.58999634, "regularMarketChange": -1.64, "regularMarketDayRange": "34.26 - 36.46", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4149593, "fiftyTwoWeekLowChange": 32.465, "fiftyTwoWeekLowChangePercent": 17.407507, "fiftyTwoWeekRange": "1.865 - 48.26", "fiftyTwoWeekHighChange": -13.9299965, "fiftyTwoWeekHighChangePercent": -0.2886448, "fiftyTwoWeekChangePercent": 657.8366, "earningsTimestamp": 1762808400, "earningsTimestampStart": 1762808400, "earningsTimestampEnd": 1762808400, "isEarningsDateEstimate": false, "corporateActions": [], "postMarketTime": 1769213460, "regularMarketTime": 1769202000, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.55935, "regularMarketPrice": 34.33, "epsTrailingTwelveMonths": -1.02, "epsForward": -1.21111, "epsCurrentYear": -1.09444, "priceEpsCurrentYear": -31.367641, "fiftyDayAverageChange": -0.44599915, "fiftyDayAverageChangePercent": -0.012824912, "twoHundredDayAverageChange": 21.212427, "twoHundredDayAverageChangePercent": 1.6170998, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]